G. Rizzo et al., RELEASE OF VASOACTIVE AGENTS DURING CORDOCENTESIS - DIFFERENCES BETWEEN NORMALLY GROWN AND GROWTH-RESTRICTED FETUSES, American journal of obstetrics and gynecology, 175(3), 1996, pp. 563-570
OBJECTIVE: The purpose of this study was to evaluate whether cordocent
esis is associated with the release of vasoactive substances and wheth
er there are differences between normally grown and growth-restricted
fetuses. STUDY DESIGN: B-Keto-prostaglandin F-1 proportional to (the s
table metabolite of prostacyclin), endothelin-1, and cyclic guanosine
monophosphate were measured in fetal blood at the beginning and closin
g of cordocentesis in 30 normally grown fetuses and 25 growth-restrict
ed fetuses. This latter group was characterized by abnormal Doppler in
dex values in umbilical artery and middle cerebral artery, suggestive
of chronic hypoxemia as the causative factor of the impaired growth. I
n six growth-restricted fetuses bradycardia occurred at the end of the
procedure. Umbilical artery pulsatility index was measured by Doppler
ultrasonography immediately before and after the procedure. RESULTS:
The median interval between the two blood samples obtained by cordocen
tesis was 90 seconds (range 60 to 320 seconds). During this interval a
significant rise of 6-keto-prostaglandin F-1 proportional to (P less
than or equal to 0.0001) and endothelin-1 (p = 0.03) was evidenced in
normally grown fetuses. The increase in 6-keto-prostaglandin F-1 alpha
was significantly related (r = 0.52, p = 0.002) to the fall or umbili
cal artery pulsatility index occurring after the procedure. In growth-
restricted fetuses cordocentesis induced a marked increase of endothel
in-1 (p = 0.0002), which was significantly related to the severity of
acidosis (r = 0.52, p = 0.018), whereas no modifications were evidence
d for the other agents tested. The increase of endothelin-1 was higher
in those growth-restricted fetuses showing bradycardia at the end of
the procedure than in growth-restricted fetuses that did not (p = 0.04
). The variations of the vasoactive substances assayed were not signif
icantly related to the type of procedure (transamniotic or transplacen
tal), the amount of blood aspirated during the procedure, the interval
elapsing between the first and second samples, the gestational age at
which the procedure was performed, and the degree of fetal smallness.
CONCLUSION: Cordocentesis induces the rapid release of vasoactive sub
stances and the effect differs between normally grown and growth-restr
icted fetuses. This may explain the different hemodynamic response and
the higher rate of complications occurring in the latter group after
cardocentesis. (Am J Obstet Gynecol 1996;175:563-70.)